[Concentrations of phenylbutazone in the blood following use of Butazolidin ointment].
作者信息
Hansen E C, Nielsen E
出版信息
Ugeskr Laeger. 1972 Jan 31;134(5):208-10.
PMID:5010808
Abstract
摘要
相似文献
1
[Concentrations of phenylbutazone in the blood following use of Butazolidin ointment].[使用保泰松软膏后血液中保泰松的浓度]
Ugeskr Laeger. 1972 Jan 31;134(5):208-10.
2
Absorption of phenylbutazone from a paste formulation administered orally to the horse.
Res Vet Sci. 1986 Sep;41(2):200-6.
3
Studies on a new paste preparation of phenylbutazone.
Vet Rec. 1983 Jun 25;112(26):602-7. doi: 10.1136/vr.112.26.602.
4
[Bioequivalence of phenylbutazone preparations following a single intramuscular administration].[单次肌内注射后保泰松制剂的生物等效性]
Arzneimittelforschung. 1984;34(6):721-3.
5
[Phenylbutazone ointment following haemorrhoidectomy].
Ugeskr Laeger. 1972 Sep 25;134(39):2037-8.
6
Phenylbutazone: factors influencing plasma concentrations.保泰松：影响血浆浓度的因素
J Int Med Res. 1977;5 Suppl 2:15-9.
7
[ON THE EFFECT OF BUTAZOLIDIN IN OINTMENT FORMS].[关于布他唑立丁软膏剂的作用]
Med Welt. 1964 Jun 20;25:1383-4.
8
[Parameters influencing the clinical action of phenylbutazone ointments].[影响保泰松软膏临床作用的参数]
Pharmazie. 1984 Sep;39(9):616-7.
9
The physiologic availability of solid dosage forms of phenylbutazone. I. In vivo physiologic availability and pharmacologic considerations.保泰松固体剂型的生理可利用性。I. 体内生理可利用性及药理学考量。
J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):177-86.
10
Pharmacokinetic studies on phenylbutazone in children.
Farmaco Sci. 1968 Oct;23(10):897-906.
引用本文的文献
1
Clinical pharmacokinetics of phenylbutazone.保泰松的临床药代动力学
Clin Pharmacokinet. 1978 Sep-Oct;3(5):369-80. doi: 10.2165/00003088-197803050-00003.
Zotero 插件